Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF00432675PMID 6791217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SALIVARY EXCRETION OF SULPHONAMIDES AND BARBITURATES BY COWS AND GOATS.

  2009cited by this paper
• Plasma levels of imipramine and desipramine in man after different routes of administration

  2004cited by this paper
• Vereinfachte Lithiumeinstellung durch Belastungstest

  2004cited by this paper
• Prediction of dosage of lithium carbonate: use of a standard predictive method.

  1980cited by this paper
• Prediction of Maintenance Dose Required to Attain a Desired Drug Concentration at Steady-state From a Single Determination of Concentration After an Initial Dose

  1980cited by this paper
• Monitoring Lithium Dose Levels: Estimation of Lithium in Saliva

  1980cited by this paper
• Amitriptyline plasma concentration and clinical response.

  1979cited by this paper
• Plasma tricyclic drug levels in amitriptyline-treated depressed patients

  1979cited by this paper
• Desipramine plasma levels and clinical response in depressed outpatients.

  1979cited by this paper
• Amitriptyline plasma concentration and clinical response.

  1979cited by this paper
• Report from the WHO Collaborative Reference Center for the Study of Psychotropic Drugs in Denmark.

  1979cited by this paper
• Prediction of steady‐state imipramine and desmethylimipramine plasma concentrations from single‐dose data

  1979cited by this paper
• Dosage Adjustment from Simple Nortriptyline Spot Level Predictor Tests in Depressed Patients

  1979cited by this paper
• Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.

  1979cited by this paper
• Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.

  1978cited by this paper
• Test dose response in schizophrenia: chlorpromazine blood and saliva levels.

  1978cited by this paper
• AMITRIPTYLINE PLASMA CONCENTRATION AND CLINICAL EFFECT

  1978cited by this paper
• Relationship between plasma and salivary concentrations of amitriptyline.

  1978cited by this paper
• Prediction of steady state plasma concentration of imipramine [proceedings].

  1978cited by this paper
• AMITRIPTYLINE PLASMA-CONCENTRATION AND CLINICAL EFFECT: A World Health Organisation Collaborative Study

  1978cited by this paper
• Correlation between plasma levels of nortriptyline and clinical effects.

  1978cited by this paper
• Nortriptyline in depressed patients with high plasma levels. II

  1978cited by this paper
• Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.

  1978cited by this paper
• Prediction of steady state plasma concentration of imipramine [proceedings].

  1978cited by this paper
• Drug concentration in saliva

  1978cited by this paper
• Prediction of individual dosage of nortriptyline.

  1978cited by this paper
• Therapeutic Drug Monitoring in Saliva

  1978cited by this paper
• Clinical implications of imipramine plasma levels for depressive illness.

  1977cited by this paper
• Imipramine: Clinical effects and pharmacokinetic variability

  1977cited by this paper
• Amitriptyline plasma levels and clinical response in primary depression

  1977cited by this paper
• Pharmacokinetic comparison of the one-point method with other methods in predicting steady state drug concentrations in multiple dosing.

  1977cited by this paper
• Plasma Level Monitoring of Tricyclic Antidepressant Therapy

  1977cited by this paper
• The 24-hour lithium level as a prognosticator of dosage requirements: a 2-year follow-up study.

  1976cited by this paper
• Relationship between the pharmacokinetics and pharmacodynamics of procainamide

  1976cited by this paper
• The 24-hour lithium level as a prognosticator of dosage requirements: a 2-year follow-up study.

  1976cited by this paper
• A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detector.

  1975cited by this paper
• [Rationalized lithium adjustment by load-test (author's transl)].

  1975cited by this paper
• Bioavailability testing and clinical significance.

  1974cited by this paper
• Bioavailability testing and clinical significance.

  1974cited by this paper
• The efficacy of antidepressant drugs. A review of research (1958-1972).

  1974cited by this paper
• Pharmacokinetics of tolbutamide: Prediction by concentration in saliva

  1974cited by this paper
• The 24-hour serum lithium level as a prognosticator of dosage requirements.

  1973cited by this paper
• Drug therapoy of clinical depressions--current status and implications for research on neuropharmacology of the affective disorders.

  1972cited by this paper
• Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single-dose plasma-level data

  1972cited by this paper
• Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses — A cross-over study

  1972cited by this paper
• Influence of repetitive dosing of tetracyclines on biologic half‐life in serum

  1969cited by this paper
• Diagnosis and Drug Treatment of Psychiatric Disorders

  1969cited by this paper
• Diagnosis and Drug Treatment of Psychiatric Disorders

  1969cited by this paper
• Grundlagen der Pharmakokinetik

  1968cited by this paper
• Streptomycin in the blood; chemical determinations after single and repeated intramuscular injections.

  1948cited by this paper

• THERAPEUTIC DRUG MONITORING IN SALIVA

  2020cites this paper
• Evaluation of Sialometric Analysis of Patients Suffering from Depressive Disorders.

  2017cites this paper
• Salivary Analysis of Drugs—Potential and Difficulties

  2008cites this paper
• The Use of Oral Fluid for Therapeutic Drug Management

  2007cites this paper
• Distribution of 3,4-Methylenedioxymethamphetamine (MDMA) in non conventional matrices and its applications in clinical toxicology

  2005cites this paper
• Prediction of haloperidol steady-state levels in plasma after a single test dose.

  1996cites this paper
• Evaluation of the Salivette as sampling device for monitoring beta-adrenoceptor blocking drugs in saliva.

  1995cites this paper
• Pharmacokinetic Optimisation of Tricyclic Antidepressant Therapy

  1993cites this paper
• Clinical Correlates of Drugs in Saliva

  1993cites this paper
• Therapeutic Drug Monitoring in Saliva

  1992cites this paper
• Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methods.

  1991cites this paper
• Steady-state plasma level prediction for haloperidol from a single test dose.

  1991cites this paper
• Saliva and plasma desipramine levels in Asian and Caucasian volunteers.

  1991cites this paper
• Clinical Pharmacokinetics of Imipramine and Desipramine

  1990cites this paper
• Validity of a Two‐Point Acetaminophen Pharmacokinetic Study

  1990cites this paper
• Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity.

  1989cites this paper
• Simplified approaches to the determination of antipyrine pharmacokinetic parameters.

  1988cites this paper
• Methylphenidate salivary levels in children.

  1987cites this paper
• [Critical evaluation of the value and limitations of plasma assays of imipramine derivatives for therapeutic monitoring].

  1986cites this paper
• Pharmacokinetics of desipramine in Caucasian and Asian volunteers.

  1986cites this paper
• Possible nonlinear pharmacokinetics of desipramine after once daily dosing.

  1986cites this paper
• Monitoring plasma concentration of nortriptyline. Methodological, pharmakokinetic and clinical aspects.

  1985cites this paper
• Clearance concept in salivary drug excretion. Part I: theory.

  1983cites this paper
• Plasma drug levels and clinical response to antidepressants.

  1983cites this paper
• Usefulness of single plasma desipramine levels.

  1983cites this paper